⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7518752 | 1.00 | — | — | |
| SCHEMBL5728937 | 0.79 | — | — | |
| SCHEMBL5728940 | 0.77 | — | — | |
| SCHEMBL1676698 | 0.74 | — | — | |
| SCHEMBL1676699 | 0.74 | — | — | |
| SCHEMBL9632102 | 0.72 | — | — | |
| SCHEMBL4611334 | 0.72 | — | — | |
| SCHEMBL3598285 | 0.72 | — | — | |
| SCHEMBL9798002 | 0.72 | — | — | |
| SCHEMBL9764811 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777535-B1 | USEFUL FOR TREATING CONDITIONS WHICH ARISE OR ARE EXACERBATED BY ANGIOGENESIS | ABBOTT LABORATORIES | 2004-08-17 | — | — | US | claimed |
| EP-1242455-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | Abbott Laboratories (US) | 2002-09-25 | — | — | EP | claimed |
| WO-2001038397-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | claimed |
| US-20070059699-A1 | Methods for detecting toxic and non-toxic cyanobacteria | SIVONEN KAARINA | 2007-03-15 | — | — | US | disclosed |
| EP-1629114-A2 | METHOD FOR DETECTING TOXIC AND NON-TOXIC CYANOBACTERIA | Helsingin Yliopisto (FI) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004104211-A2 | METHOD FOR DETECTING TOXIC AND NON-TOXIC CYANOBACTERIA | HELSINGIN YLIOPISTO (FI) | 2004-12-02 | — | — | WO | disclosed |
| US-6777535-B1 | USEFUL FOR TREATING CONDITIONS WHICH ARISE OR ARE EXACERBATED BY ANGIOGENESIS | ABBOTT LABORATORIES | 2004-08-17 | — | — | US | disclosed |
| EP-1242455-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | Abbott Laboratories (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001038397-A1 | N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY | ABBOTT LABORATORIES (US) | 2001-05-31 | — | — | WO | disclosed |